Skip to main content
Fig. 5 | Acta Neuropathologica Communications

Fig. 5

From: Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Fig. 5

Relevant post-Audencel immunovariables and outcome. a ELISPOT IFNγ significantly correlated with OS (p = 0.022, n = 22). Patients with “high” ELISPOT IFNγ (above the median) also showed a significantly better OS (p = 0.003, n = 22). b CD8+ correlated with OS (p = 0.026, n = 34) and separated survival curves significantly (p < 0.001, n = 34)

Back to article page